全球化學發光免疫分析儀市場規模、佔有率、成長分析、依產品、依應用、依最終用戶 - 產業預測 2024-2031

2022年，全球化學發光免疫分析儀市場規模為54.1億美元，預計將從2023年的58.2億美元成長到2031年的103.7億美元，在預測期內（2024-2031年）複合年成長率為7.5 %。

近年來，慢性病和傳染病病例的增加促使全球化學發光市場的成長。儘管如此，由於它們在識別與各種醫學疾病相關的這些標記物方面具有很高的敏感性和特異性，因此它們在診斷實驗室中發揮著至關重要的作用。使用化學發光免疫分析儀，可以輕鬆識別或追蹤癌症、心臟病和傳染病等疾病。因此，在高度重視醫療保健，特別是疾病的早期發現的現代社會，對準確、快速的診斷儀器的持續需求。由於全球醫療保健成本上升以及早期診斷意識的提高，該市場正在發展。除了政府之外，私人醫療機構也正在採用先進的診斷技術，以提高病患的治療效果。

目錄

執行摘要

• 市場概況
• 命運之輪

研究方法論

• 資訊採購
• 二手和主要資料來源
• 市場規模估計
• 市場假設與限制

母公司市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題

主要市場洞察

• 技術分析
• 定價分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• 啟動分析
• 原料分析
• 創新矩陣
• 管道產品分析
• 總體經濟指標
• 頂級投資分析
• 成功的關鍵因素
• 競爭程度

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題
• 監管環境
• 波特分析
• 對未來顛覆的特別見解

全球化學發光免疫分析儀市場（依產品）

• 市場概況
• 全自動化學發光免疫分析儀及半自動化學發光免疫分析儀

全球化學發光免疫分析儀市場（依應用）

• 市場概況
• 傳染病檢測
• 內分泌系統測試
• 心臟標記測試
• 腫瘤學測試
• 自體免疫疾病檢測
• 過敏測試
• 其他

全球化學發光免疫分析儀市場（依最終用戶）

• 市場概況
• 醫院
• 診斷實驗室
• 研究機構
• 和即時檢測

全球化學發光免疫分析儀市場規模（依地區）

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • MEA 的其餘部分

競爭格局

• 前 5 名企業比較
• 2023 年關鍵參與者的市場定位
• 主要市場參與者所採取的策略
• 最佳制勝策略
• 近期市集活動
• 主要公司市佔率 (%), 2023

主要公司簡介

• Roche Diagnostics
• Abbott
• Siemens Healthcare
• Ortho Clinical Diagnostics
• Beckman Coulter
• Danaher (Beckman Coulter Life Sciences)
• Johnson & Johnson (Ortho-Clinical Diagnostics)
• DiaSorin
• Luminex Corporation
• Tosoh Bioscience
• Snibe Diagnostics
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Sysmex Corporation
• Hytest Ltd.
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• ARCHITECT Diagnostics, Inc.
• Euroimmun Medizinische Labordiagnostika AG
• Mesan Pharma
• Abbott Point-of-Care Inc.

Global Chemiluminescence Immunoassay Analyzers Market size was valued at USD 5.41 billion in 2022 and is poised to grow from USD 5.82 billion in 2023 to USD 10.37 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

The rise in chronic and infectious disease cases has led to a growth in the global chemiluminescence market in recent years. Nonetheless, because of their great sensitivity and specificity in identifying these markers associated with various medical disorders, they play a crucial role in diagnostic laboratories. Using chemiluminescence immunoassay analyzers, ailments like cancer, heart problems, and infectious infections can be easily identified or tracked. Because of this, there is a continuing need for accurate and quick diagnostic instruments in the modern society, which places a strong emphasis on health care, particularly the early detection of disease. The market is developing as a result of rising healthcare costs globally and rising awareness of early diagnosis. Private healthcare institutions are embracing advanced diagnostic technology, in addition to governments, toward enhancing patients' results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Chemiluminescence Immunoassay Analyzers Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Chemiluminescence Immunoassay Analyzers Market Segmental Analysis

The global chemiluminescence immunoassay analyzers market is segmented into four major segments i.e. by product type, application, end user, and region. Based on type, it is divided into fully automated chemiluminescence immunoassay analyzers and semi-automated chemiluminescence immunoassay analyzers. Based on application, it is bifurcated as infectious disease testing, endocrine system testing, cardiac marker testing, oncology testing, autoimmune disease testing, allergy testing, and others. Based on end users it is segregated into hospitals, diagnostic laboratories, research institutes, and point-of-care testing. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Drivers of the Global Chemiluminescence Immunoassay Analyzers Market

More advanced tools are needed for accurate and timely diagnosis due to the increased prevalence of infectious and chronic diseases. Chemiluminescence immunoassay analyzers, which are frequently used in many diagnostics laboratories, are among those well-known brands. The global emphasis on illness prevention and early detection also contributes to the rise in demand for these analyzers. This is true since technical advancements are crucial, and regular upgrades raise the bar, improve accuracy, and so forth.

Restraints in the Global Chemiluminescence Immunoassay Analyzers Market

The substantial upfront and ongoing costs of purchasing and maintaining these advanced diagnostic devices are one of the primary market barriers. Smaller healthcare facilities and labs may find it more difficult to implement this cutting-edge equipment due to the significant initial cost. Furthermore, there may be a learning curve for medical practitioners due to the intricacy of these analyzers and their data interpretation procedures, which could slow down and reduce the accuracy of diagnoses. The market's growth may also be hampered by regional regulatory obstacles and compliance problems, which call for adherence to various standards and approval procedures.

Market Trends of the Global Chemiluminescence Immunoassay Analyzers Market

These analyzers' automated artificial intelligence (AI) integration speeds up diagnostic interpretations and laboratory turnaround times. It also makes administering tests easier, reduces the time needed to get results, and improves accuracy. Furthermore, there is a growing interest in expanding the applications of these devices to include hormone diagnostic research, microbial infection detection, and cancer diagnosis. In order to meet the expanding demand for PoC testing and remote diagnostics, manufacturers are also concentrating on creating more user-friendly and portable analyzers.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Chemiluminescence Immunoassay Analyzers Market by Product

• Market Overview
• Fully Automated Chemiluminescence Immunoassay Analyzers and Semi-Automated Chemiluminescence Immunoassay Analyzers

Global Chemiluminescence Immunoassay Analyzers Market by Application

• Market Overview
• Infectious Disease Testing
• Endocrine System Testing
• Cardiac Marker Testing
• Oncology Testing
• Autoimmune Disease Testing
• Allergy Testing
• and Others

Global Chemiluminescence Immunoassay Analyzers Market by End User

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• and Point-of-Care Testing

Global Chemiluminescence Immunoassay Analyzers Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (Beckman Coulter Life Sciences)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (Ortho-Clinical Diagnostics)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Snibe Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hytest Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARCHITECT Diagnostics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Euroimmun Medizinische Labordiagnostika AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesan Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Point-of-Care Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments